The expression levels of TIGIT and CD226 depend on the T cell subset and activation level, and an increasing number of studies have demonstrated the importance of the TIGIT/CD226 axis in tumors and autoimmune diseases [9, 46, 47]. This evidence concerns the gene TIGIT and autoimmune disease.